Viscosupplementation Market Report: Trends, Forecast and Competitive Analysis to 2031

Viscosupplementation Market Trends and Forecast

The future of the global viscosupplementation market looks promising with opportunities in the hospital and clinic markets. The global viscosupplementation market is expected to grow with a CAGR of 3.6% from 2025 to 2031. The major drivers for this market are the increasing prevalence of osteoarthritis, the rising geriatric population with joint issues, and the growing adoption of non-surgical treatment options.

• Lucintel forecasts that, within the type category, single injection is expected to witness the highest growth over the forecast period.
• Within the application category, clinic is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Viscosupplementation Market

The viscosupplementation market is undergoing a notable evolution, shaped by advancements in medical science and changing patient and provider preferences. These emerging trends are focused on enhancing treatment efficacy, improving patient convenience, and expanding the application of viscosupplementation beyond the traditional knee joint. The market is moving toward more personalized and convenient treatment options.

• Shift to Single-Injection Regimens: There is a growing trend toward single-injection viscosupplementation products over multi-dose regimens. This trend is impacting the market by improving patient compliance and reducing the number of clinic visits required for a full course of treatment. This enhances convenience for both patients and healthcare providers, making the therapy more accessible and appealing.
• Non-Animal Sourced Hyaluronic Acid: The market is seeing an increased preference for non-animal sourced hyaluronic acid (HA), typically derived from bacterial fermentation. This trend is impacting the market by reducing the risk of allergic reactions and viral contamination associated with avian-derived products. It also addresses the growing demand for vegan and ethically sourced medical products, broadening the market's appeal.
• Expansion into Other Joints: While historically focused on the knee, viscosupplementation is now being increasingly used for other joints, such as the hip and shoulder. This trend is expanding the market by addressing a wider range of osteoarthritis and joint pain applications. The development of specific formulations and injection techniques for these joints is creating new revenue streams and therapeutic opportunities.
• Integration with Ultrasound Guidance: The use of ultrasound guidance for injections is becoming a standard practice. This trend is improving the accuracy and precision of viscosupplementation injections, particularly for difficult-to-access joints like the hip. It is enhancing the efficacy of the treatment and increasing patient confidence in the procedure, leading to better clinical outcomes and wider adoption.
• Combination Therapies and Formulations: There is an emerging trend of developing combination products that include hyaluronic acid along with other therapeutic agents like corticosteroids or anti-inflammatory drugs. This trend is impacting the market by offering enhanced pain relief and anti-inflammatory benefits in a single injection. It provides a more comprehensive treatment option for patients with severe pain and inflammation.

These trends are reshaping the viscosupplementation market by creating a more patient-centric, technologically advanced, and diversified landscape. The shift toward single-injection, non-animal-sourced products and the expansion into new applications are driving growth and innovation, ultimately improving the quality of life for a wider range of patients with joint-related disorders.

Recent Developments in the Viscosupplementation Market

The viscosupplementation market is currently defined by a series of key developments aimed at improving product efficacy, patient convenience, and market access. These developments are a direct response to the global rise in osteoarthritis cases and the continuous quest for non-invasive treatment options. The industry is focused on bringing more advanced and patient-friendly solutions to the forefront of orthopedic care.

• New Product Approvals and Launches: A significant development is the continuous stream of new products, particularly single-injection formulations, receiving regulatory approvals. This is impacting the market by increasing the range of treatment options available to patients and physicians. It also intensifies market competition, spurring further innovation and a focus on long-lasting, high-molecular-weight formulations for sustained pain relief.
• Focus on Regenerative Medicine: There is a growing trend toward combining viscosupplementation with other regenerative therapies, such as platelet-rich plasma (PRP) or stem cell injections. This is impacting the market by creating a new category of combination therapies that aim to not only lubricate the joint but also potentially stimulate tissue repair. It offers a more holistic approach to managing osteoarthritis, attracting a new segment of patients.
• Enhancements in Injection Technology: Recent developments include the refinement of injection delivery systems and the increasing use of pre-filled syringes. This is impacting the market by making the procedure safer, more convenient, and more precise. These advancements reduce the risk of contamination and simplify the administration process for healthcare professionals, especially in outpatient and ambulatory care settings.
• Clinical Research and Evidence: There has been a renewed focus on large-scale clinical trials and meta-analyses to establish the long-term efficacy and safety of viscosupplementation. This is impacting the market by strengthening the clinical evidence base, which is crucial for influencing physician adoption and securing favorable reimbursement policies. It helps to differentiate products and builds confidence in the therapy's role in orthopedic practice.
• Targeted Marketing and Patient Education: Companies are increasingly investing in patient education campaigns and targeted marketing to raise awareness about viscosupplementation as a viable non-surgical option. This is impacting the market by empowering patients to have informed discussions with their physicians, leading to earlier diagnosis and treatment. It also helps to overcome a lack of awareness, which has been a traditional barrier to growth.

These developments are impacting the viscosupplementation market by creating a more dynamic and competitive landscape. The combination of product innovation, improved delivery methods, and a strong focus on clinical evidence and patient education is driving the market forward and solidifying viscosupplementation's position as a key treatment for joint pain.

Strategic Growth Opportunities in the Viscosupplementation Market

The viscosupplementation market holds significant strategic growth opportunities across key applications, driven by a global increase in osteoarthritis prevalence and the demand for non-surgical interventions. As healthcare systems evolve and patient demographics shift, market players can capitalize on these opportunities by focusing on specific, high-potential areas. These strategic applications are key to expanding market share and driving innovation.

• Knee Osteoarthritis: This remains the largest and most established application, offering opportunities through the development of long-lasting single-injection products. The impact is a larger addressable market, as more patients seek to delay or avoid total knee replacement surgery. Focusing on this segment with advanced formulations that provide extended pain relief can secure a competitive advantage.
• Hip Osteoarthritis: The hip joint represents a high-growth opportunity due to the difficulty and cost associated with hip replacement surgery. The impact is a new patient population for viscosupplementation, which offers a minimally invasive alternative. Developing products and specialized delivery techniques for hip injections, often guided by ultrasound, is a key strategy for market expansion.
• Shoulder and Small Joint Pain: This application is a significant growth area for viscosupplementation in sports medicine and rheumatology. The impact is an expansion of the therapy to address a broader range of musculoskeletal conditions beyond the major weight-bearing joints. Targeted products and educational efforts for sports physicians and rheumatologists can unlock this underserved segment.
• Combination with Regenerative Therapies: A strategic opportunity lies in integrating viscosupplementation with other regenerative treatments like platelet-rich plasma (PRP). The impact is a premium product offering that provides synergistic benefits of both joint lubrication and tissue healing. This allows for a higher price point and positions the therapy as a comprehensive solution for joint health.
• Emerging Markets in Asia-Pacific: The Asia-Pacific region, particularly countries like China and India, offers immense growth potential due to their vast populations and increasing healthcare spending. The impact is a massive expansion of the patient base. Strategic investments in local manufacturing, distribution networks, and physician education are crucial to capitalize on this demographic shift.

These opportunities are impacting the viscosupplementation market by encouraging diversification and specialization. Instead of a one-size-fits-all approach, companies are now focusing on targeted applications, developing specialized products, and expanding into new geographic markets, which is driving overall market growth and transforming the competitive landscape.

Viscosupplementation Market Driver and Challenges

The viscosupplementation market is influenced by a complex interplay of major drivers and challenges, which include various technological, economic, and regulatory factors. The rising prevalence of osteoarthritis and a strong desire for non-invasive therapies are key drivers, while issues such as a lack of uniform clinical guidelines and high product costs present significant hurdles. Navigating these factors is essential for sustained growth and market leadership.

The factors responsible for driving the viscosupplementation market include:

1. Rising Prevalence of Osteoarthritis: The increasing global prevalence of osteoarthritis, especially among the aging population and due to factors like obesity, is the primary driver. This creates a continuously expanding patient pool in need of effective pain management, thereby boosting the demand for viscosupplementation as a therapeutic option.

2. Demand for Non-Surgical Treatments: Patients are increasingly seeking minimally invasive alternatives to joint replacement surgery. Viscosupplementation provides an attractive solution, as it offers pain relief with lower risks, reduced recovery time, and significantly lower costs compared to surgery, driving its adoption as a preferred treatment modality.

3. Advancements in Product Formulation: The development of new-generation, long-lasting hyaluronic acid formulations, particularly single-injection products, is a key driver. These innovations improve patient convenience and compliance, making the therapy more appealing. It also allows for more targeted and effective treatments, leading to better clinical outcomes and greater physician confidence.

4. Favorable Reimbursement Policies: In developed economies, favorable reimbursement policies from government and private insurers for viscosupplementation procedures are a major driver. This reduces the out-of-pocket cost for patients, making the therapy more accessible and affordable, which is crucial for its widespread adoption in clinical practice.

5. Increasing Awareness and Education: Growing awareness among both patients and healthcare providers about the benefits and applications of viscosupplementation is a significant driver. Targeted educational campaigns and a stronger clinical evidence base are empowering patients to seek out this treatment, leading to earlier diagnosis and intervention.

Challenges in the viscosupplementation market are:

1. Lack of Uniform Clinical Guidelines: A major challenge is the lack of a universal consensus on the efficacy and appropriate use of viscosupplementation, which results in varying clinical guidelines across regions and medical societies. This can lead to physician skepticism and inconsistent adoption rates, hindering market growth and creating regulatory ambiguity.

2. High Cost and Limited Reimbursement: Despite long-term cost benefits, the high upfront cost of viscosupplementation products and limited reimbursement coverage in some developing markets remain a significant challenge. This can restrict patient access and adoption, especially in regions with a high proportion of out-of-pocket healthcare expenses.

3. Competition from Alternative Therapies: The market faces competition from other joint pain management options, including oral analgesics, corticosteroids, and emerging regenerative treatments like PRP and stem cell therapy. This creates a crowded therapeutic landscape, and market players must continually innovate and provide strong clinical evidence to justify the use of viscosupplementation.

The viscosupplementation market is propelled by strong drivers, including an aging population and a preference for minimally invasive treatments, which are fueling its growth. However, it is simultaneously constrained by critical challenges such as inconsistent clinical guidelines and high costs. Overcoming these challenges through robust clinical evidence and strategic market entry will be vital for the market's long-term sustainability and success.

List of Viscosupplementation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies viscosupplementation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the viscosupplementation companies profiled in this report include-

• Sanofi
• Anika Therapeutics
• Seikagaku
• Zimmer Biomet
• Bioventus
• Ferring
• LG Chem
• Freda
• Haohai Biological
• Shanghai Jingfeng

Viscosupplementation Market by Segment

The study includes a forecast for the global viscosupplementation market by type, application, and region.

Viscosupplementation Market by Type [Value from 2019 to 2031]:

• Single Injection
• Three Injection
• Five Injection

Viscosupplementation Market by Application [Value from 2019 to 2031]:

• Hospitals
• Clinics
• Others

Country Wise Outlook for the Viscosupplementation Market

The viscosupplementation market is experiencing significant developments driven by an aging global population and the rising prevalence of osteoarthritis. As patients and healthcare providers increasingly seek non-surgical treatments for joint pain, there's a growing demand for advanced hyaluronic acid injections. These developments are marked by innovations in product formulations, delivery methods, and evolving reimbursement policies across different regions.

• United States: The US market is characterized by a strong focus on single-injection products, which offer convenience and improved patient compliance. Recent developments include new product approvals by the FDA, an increase in treatment at ambulatory surgical centers, and a growing trend of using viscosupplementation to delay the need for total joint replacement surgeries.
• China: China's market is rapidly expanding, fueled by an increasing geriatric population, rising healthcare expenditure, and a growing middle class with greater access to advanced medical treatments. The focus is on expanding access to care and increasing awareness of non-surgical options for osteoarthritis, with domestic manufacturers playing a more prominent role.
• Germany: Germany leads the European market with a robust healthcare system and favorable reimbursement policies. The market is driven by a high prevalence of osteoarthritis and a strong preference for non-invasive treatments. There is a continuous emphasis on clinical evidence and high-quality, non-animal-derived hyaluronic acid products to ensure patient safety and efficacy.
• India: India's viscosupplementation market is growing at a fast pace, largely due to a large patient pool, improving healthcare infrastructure, and rising awareness among both patients and physicians. Government initiatives and increasing foreign investment in the healthcare sector are creating new opportunities for market players to introduce advanced products.
• Japan: Japan has a well-established viscosupplementation market with a high rate of adoption, driven by a significantly aging population and a strong emphasis on clinical research. The market is defined by a preference for long-lasting, single-injection treatments and the use of products with proven efficacy in managing symptoms of various joint-related conditions.

Features of the Global Viscosupplementation Market

Market Size Estimates: Viscosupplementation market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Viscosupplementation market size by type, application, and region in terms of value ($B).

Regional Analysis: Viscosupplementation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the viscosupplementation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the viscosupplementation market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the viscosupplementation market by type (single injection, three injection, and five injection), application (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order. Show more